# TNF-α Antagonists Mitigate Systemic Inflammatory Response After Cardiac Arrest.

> **NCT07176754** · NA · NOT_YET_RECRUITING · sponsor: **Peking University Third Hospital** · enrollment: 208 (estimated)

## Conditions studied

- Cardiac Arrest (CA)
- Post Cardiac Arrest Syndrome

## Interventions

- **DRUG:** Infliximab
- **DRUG:** Sodium chloride injection USP, 0.9% (placebo)

## Key facts

- **NCT ID:** NCT07176754
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2028-07-31
- **Final completion:** 2028-10-31
- **Target enrollment:** 208 (ESTIMATED)
- **Last updated:** 2025-09-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07176754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07176754, "TNF-α Antagonists Mitigate Systemic Inflammatory Response After Cardiac Arrest.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07176754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*